http://pediatrics.aappublications.or...ll/123/6/e1103
Efficacy of Pneumococcal Vaccination in Children Younger Than 24 Months: A Meta-Analysis
full text available in the link
Efficacy of Pneumococcal Vaccination in Children Younger Than 24 Months: A Meta-Analysis
Quote:
| RESULTS. The efficacy of pneumococcal conjugate vaccine in the reduction of invasive pneumococcal disease was 89% involving vaccine serotypes in both the intention-to-treat and per-protocol analyses and ranged from 63% to 74% for all serotypes. The efficacy to prevent acute otitis media sustained by vaccine serotypes was 55% in the intention-to-treat and 57% in the per-protocol analyses, whereas it was 29% to prevent otitis involving all serotypes in the per-protocol analysis. Finally, in the intention-to-treat and per-protocol analyses, the efficacy to prevent clinical pneumonia was 6% and 7%, respectively, whereas for the prevention of radiograph-confirmed pneumonia it was 29% and 32%, respectively. |









) and yet another used hep A as a placebo. Two studies done in Africa do not mention what their placebo was.
: sloppy of me. Yes the vaccines are controls and yes, some of these studies claim to have tested not only the efficacy, but also the safety of the vaccine being studied by using an experimental vaccine as the control.